Ab Science 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow A8D.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences is a biopharmaceutical company that competes with AB Science in the development of treatments for various diseases, including those in oncology and inflammatory diseases, areas where AB Science is also active.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that competes across multiple segments, including those targeted by AB Science, such as cancer and chronic inflammatory diseases, with a broad portfolio of drugs.
AMGEN
AMGN
Mkt Cap187.56B
Amgen is a biotech company focusing on human therapeutics, with products that compete in the oncology and inflammatory disease markets, directly competing with AB Science's research and drug development efforts.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a research-based biopharmaceutical company with a wide range of products that compete with AB Science, especially in the fields of oncology and immunology.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG is a healthcare company that competes with AB Science in developing treatments for various diseases, including cancer and chronic inflammatory conditions, through its biotechnology and pharmaceutical divisions.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol-Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with AB Science's portfolio, especially in cancer and immune-inflammatory diseases.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is known for its contributions to healthcare and pharmaceuticals, competing with AB Science in areas such as oncology, making it a direct competitor in the development of cancer treatments.
Lilly(Eli) &
LLY
Mkt Cap837.36B
Eli Lilly and Company is a global pharmaceutical company that develops drugs in areas like oncology and autoimmune diseases, competing with AB Science in the development and marketing of treatments for similar conditions.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals is a biotechnology company that competes with AB Science in the development of medicines for the treatment of serious medical conditions, including oncology and inflammatory diseases.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of therapeutic products, competing with AB Science in areas such as oncology and respiratory diseases.

About

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Show more...
CEO
Mr. Alain Moussy MBA
Employees
40
Country
France
ISIN
FR0010557264

Listings

0 Comments

Share your thoughts

FAQ

What is Ab Science stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ab Science stocks are traded under the ticker A8D.MU.
How many employees does Ab Science have?
As of April 12, 2026, the company has 40 employees.
In which sector is Ab Science located?
Ab Science operates in the Health & Wellness sector.
When did Ab Science complete a stock split?
Ab Science has not had any recent stock splits.
Where is Ab Science headquartered?
Ab Science is headquartered in Paris, France.